SK284464B6 - Použitie zlúčeniny, vybranej zo skupiny, pozostávajúcej z vitamínu E a jeho esterov, na prípravu lieku na miestne liečenie patologických stavov sliznice - Google Patents

Použitie zlúčeniny, vybranej zo skupiny, pozostávajúcej z vitamínu E a jeho esterov, na prípravu lieku na miestne liečenie patologických stavov sliznice Download PDF

Info

Publication number
SK284464B6
SK284464B6 SK35-2001A SK352001A SK284464B6 SK 284464 B6 SK284464 B6 SK 284464B6 SK 352001 A SK352001 A SK 352001A SK 284464 B6 SK284464 B6 SK 284464B6
Authority
SK
Slovakia
Prior art keywords
vitamin
compound
mucosa
group
medicament
Prior art date
Application number
SK35-2001A
Other languages
English (en)
Slovak (sk)
Other versions
SK352001A3 (en
Inventor
Giorgio Panin
Eleonora Annunziata
Original Assignee
Giorgio Panin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11380415&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK284464(B6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Giorgio Panin filed Critical Giorgio Panin
Publication of SK352001A3 publication Critical patent/SK352001A3/sk
Publication of SK284464B6 publication Critical patent/SK284464B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SK35-2001A 1998-07-10 1999-07-05 Použitie zlúčeniny, vybranej zo skupiny, pozostávajúcej z vitamínu E a jeho esterov, na prípravu lieku na miestne liečenie patologických stavov sliznice SK284464B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT98MI001586A ITMI981586A1 (it) 1998-07-10 1998-07-10 Vitamina e e suoi esteri per l'uso nel trattamento topico di patologie delle mucose
PCT/IB1999/001238 WO2000002554A1 (en) 1998-07-10 1999-07-05 Vitamin e and esters thereof for use in the topical treatment of mucosal pathologies

Publications (2)

Publication Number Publication Date
SK352001A3 SK352001A3 (en) 2001-06-11
SK284464B6 true SK284464B6 (sk) 2005-04-01

Family

ID=11380415

Family Applications (1)

Application Number Title Priority Date Filing Date
SK35-2001A SK284464B6 (sk) 1998-07-10 1999-07-05 Použitie zlúčeniny, vybranej zo skupiny, pozostávajúcej z vitamínu E a jeho esterov, na prípravu lieku na miestne liečenie patologických stavov sliznice

Country Status (22)

Country Link
EP (1) EP1094807B1 (it)
JP (1) JP2002520281A (it)
CN (1) CN1135975C (it)
AT (1) ATE238051T1 (it)
AU (1) AU762860B2 (it)
BR (1) BR9911945A (it)
CA (1) CA2336990A1 (it)
CZ (1) CZ301019B6 (it)
DE (1) DE69907193T2 (it)
DK (1) DK1094807T3 (it)
ES (1) ES2196813T3 (it)
HU (1) HU228921B1 (it)
IL (1) IL140759A0 (it)
IT (1) ITMI981586A1 (it)
NO (1) NO20006719L (it)
NZ (1) NZ509129A (it)
PL (1) PL345500A1 (it)
PT (1) PT1094807E (it)
RU (2) RU2221561C2 (it)
SK (1) SK284464B6 (it)
TR (2) TR200100014T2 (it)
WO (1) WO2000002554A1 (it)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040077604A1 (en) 2001-12-19 2004-04-22 Lenard Lichtenberger Method and compositions employing formulations of lecithin oils and nsaids for protecting the gastrointestinal tract and providingenhanced therapeutic activity
FR2819186A1 (fr) * 2001-01-10 2002-07-12 L M D Cystine-voie orale-syndrome de l'oeil sec
FR2825088A1 (fr) * 2001-05-25 2002-11-29 Derma Dev Nouveaux esters de tocopherol, leurs procedes d'obtention et leurs utilisations
US7485666B2 (en) * 2004-06-17 2009-02-03 Kimberly-Clark Worldwide, Inc. Vaginal health products
US9993558B2 (en) 2004-10-01 2018-06-12 Ramscor, Inc. Sustained release eye drop formulations
US8541413B2 (en) * 2004-10-01 2013-09-24 Ramscor, Inc. Sustained release eye drop formulations
US20080038316A1 (en) 2004-10-01 2008-02-14 Wong Vernon G Conveniently implantable sustained release drug compositions
CA2739658C (en) * 2008-10-09 2016-11-08 Ramscor, Inc. Composition and method for treating dry eye syndrome
IT1394063B1 (it) * 2009-05-11 2012-05-25 Giuliani Spa Composizione per uso oftalmico adatta al trattamento degli stati infiammatori dell'occhio e della sindrome dell'occhio secco
JP2013500302A (ja) * 2009-07-27 2013-01-07 サンセベリノ，レナト Ｕｖ−ａ線に対する眼球内部構造保護用又は経上皮架橋術式による円錐角膜の治療用点眼液
WO2013049749A2 (en) 2011-09-29 2013-04-04 Plx Pharma Inc. pH DEPENDENT CARRIERS FOR TARGETED RELEASE OF PHARMACEUTICALS ALONG THE GASTROINTESTINAL TRACT, COMPOSITIONS THEREFROM, AND MAKING AND USING SAME
ES2700983T3 (es) * 2012-06-08 2019-02-20 Univ Ohio State Tratamiento de lesión cicatricial usando tocotrienol
DE202014106007U1 (de) * 2014-07-22 2015-07-23 Bio.Lo.Ga. S.R.L. Zusammensetzung zur Verwendung in der Vorbeugung und Behandlung allergischer Rhinitis
ES2757349T3 (es) * 2014-10-22 2020-04-29 Bio Lo Ga Srl Composición farmacéutica para su uso en el aumento del trofismo de la mucosa nasal
JP2018507895A (ja) * 2015-03-18 2018-03-22 バイオヌークス スイス エスエー ヘルペスを処置するための方法において使用するためのジヒドロケルセチンを含む組成物
JP2017119669A (ja) * 2015-10-15 2017-07-06 ロート製薬株式会社 異物感改善用眼科組成物
WO2020053783A1 (en) * 2018-09-12 2020-03-19 Neilos S.r.l. A composition for use in the prevention and/or treatment of epistaxis
IT202000003620A1 (it) * 2020-02-21 2021-08-21 Hulka S R L Uso di una formulazione per applicazione topica per il mantenimento dell’omeostasi vaginale
JP2023518822A (ja) 2020-03-26 2023-05-08 ピーエルエックス オプコ インコーポレイテッド ｐＨ依存的再構築が可能な医薬キャリア、その製造方法及び使用方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59216812A (ja) * 1983-05-26 1984-12-06 Dowa Yakushiyou Kk 頭髪育毛料
JP2776837B2 (ja) * 1988-08-11 1998-07-16 日本レダリー株式会社 消化性潰瘍治療剤
US5032384A (en) * 1989-01-27 1991-07-16 Block Drug Company, Inc. Compositions and method for the treatment of disease
IT1249711B (it) * 1991-09-30 1995-03-09 Boniscontro E Gazzone S R L Composizioni farmaceutiche, per uso topico, contenenti "scavengers" di radicali liberi dell'ossigeno e antibatterici,indicate nella terapia dei tessuti superficiali.
CN1039087C (zh) * 1993-12-29 1998-07-15 昆明宏达实业有限总公司 妇科病治疗保健外用药物
IT1282778B1 (it) * 1996-05-31 1998-03-31 Giorgio Panin Vitamina "e" acetato quale prodotto per applicazione topica
JPH10231243A (ja) * 1997-02-20 1998-09-02 Sekisui Chem Co Ltd 粘膜炎症外用薬

Also Published As

Publication number Publication date
JP2002520281A (ja) 2002-07-09
DE69907193T2 (de) 2004-04-08
HUP0102781A3 (en) 2002-04-29
RU2003128023A (ru) 2005-04-10
PL345500A1 (en) 2001-12-17
NO20006719D0 (no) 2000-12-29
RU2221561C2 (ru) 2004-01-20
SK352001A3 (en) 2001-06-11
CA2336990A1 (en) 2000-01-20
AU762860B2 (en) 2003-07-10
NZ509129A (en) 2003-10-31
ITMI981586A1 (it) 2000-01-10
DK1094807T3 (da) 2003-08-11
AU4385899A (en) 2000-02-01
CN1135975C (zh) 2004-01-28
HUP0102781A2 (hu) 2001-12-28
PT1094807E (pt) 2003-08-29
CN1308531A (zh) 2001-08-15
ITMI981586A0 (it) 1998-07-10
HU228921B1 (en) 2013-06-28
EP1094807A1 (en) 2001-05-02
TR200100014T2 (tr) 2001-06-21
NO20006719L (no) 2001-02-16
BR9911945A (pt) 2001-03-27
IL140759A0 (en) 2002-02-10
CZ301019B6 (cs) 2009-10-14
ES2196813T3 (es) 2003-12-16
DE69907193D1 (de) 2003-05-28
WO2000002554A1 (en) 2000-01-20
ATE238051T1 (de) 2003-05-15
CZ200136A3 (cs) 2001-08-15
EP1094807B1 (en) 2003-04-23
TR200103710T2 (tr) 2002-06-21

Similar Documents

Publication Publication Date Title
SK284464B6 (sk) Použitie zlúčeniny, vybranej zo skupiny, pozostávajúcej z vitamínu E a jeho esterov, na prípravu lieku na miestne liečenie patologických stavov sliznice
JP5118633B2 (ja) 医療用デバイスおよび医薬製剤において有用な粘膜付着性キシログルカン含有製剤
WO2012092375A1 (en) Method for treating dry eye
WO2012092378A1 (en) Method for treating blepharitis
KR101067443B1 (ko) 하이드록시클로로퀸을 함유하는 치핵 치료를 위한 국소투여용 주사제 조성물
BRPI1010325B1 (pt) composição dermatológica e/ou farmacêutica, dispositivo médico e seus usos
US5134165A (en) Method of treatment for loss of vision due to ophthalmic surgery
Habif et al. Dermatology DDX Deck E-Book
MXPA01000368A (en) Vitamin e and esters thereof for use in the topical treatment of mucosal pathologies
EP3823622A1 (en) Methods and compositions for promoting wound healing in a subject suffering from ectodermal dysplasias
EP0078533B1 (en) Medicinal composition for treating skin disorders
ROTARU et al. NOVELTIES IN THE MANAGEMENT OF ROSACEA.
Warren et al. Geriatric Dermatologic Disorders
US20190216769A1 (en) Topical Application of Delphinidin Compounds Treats Rosacea
WO2023098537A1 (zh) 丙谷二肽的新用途和包含丙谷二肽的眼用组合物
CA1184121A (en) Treatment of acne and perioral dermatitis as well as for skin infected with a herpesvirus
JP2004059440A (ja) 肌荒れ防止および粘膜修復剤
CA1260397B (en) Treatment of acne and perioral dermatitis as well as for skin infected with a herpesvirus
UA150749U (uk) Спосіб одержання фармацевтичної композиції для інтраназального введення
Al-Niaimi et al. Pre-existing and coincidental skin disease
Edwards Pustules, vesicles, bullae and erosions
Serbelloni et al. Pruritus Ani
EA002267B1 (ru) Ранозаживляющий, противовоспалительный и противоинфекционный лекарственный препарат
JP2004175808A (ja) 有効成分としてリン酸ヒスタミンを用いて損傷組織を局所的に治療するための方法および組成物
CA2591352A1 (en) Treatment for herpes simplex virus and other infectious diseases